About Juul Labs
Newsroom
Regulation and Policy
Harm Reduction
International Policies
Regulatory Filings
Disclosure and Transparency
Select Regulatory Filings (International)
Juul Labs response to the call for evidence on reforming the producer responsibility system for waste electrical and electronic equipment (WEEE)
03/07/2024
Juul Labs response to the Department of Health and Social Care Call for Evidence on youth vaping
06/06/2023
Juul Labs written evidence to UK Parliament Public Bill Committee on the Online Safety Bill
06/07/2022
Juul Labs Submission to the APPG on Vaping’s Inquiry on Achieving a Smoke-Free UK by 2030
05/27/2021
Juul Labs submission to the "Independent review of smoke-free 2030 policies" - the Khan Review
03/21/2022
Juul Labs Submission to UK Department for Health & Social Care Regarding the Post-Implementation Review of the Tobacco and Related Products Regulations 2016
03/19/2021
Juul Labs Canada - Response to Health Canada's Proposed Concentration of Nicotine in Vaping Products Regulations (CNVPR)
03/04/2021
Juul Labs’ Consolidated Response to the Preliminary Opinion of the European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) on electronic cigarettes
10/26/2020
Juul Labs Submission to the Australian Senate Select Committee On Tobacco Harm Reduction
04/11/2020
Juul Labs Submission to the New Zealand Health Selection Committee on the Smokefree Environments and Regulated Products (Vaping) Bill
04/08/2020
Juul Labs Canada response to Health Canada Market Research Survey of February, 2020
02/24/2020
Juul Labs Canada response to proposed vaping regulations in British Columbia from January, 2020
01/23/2020
Select Regulatory Filings (U.S.)
Juul Labs Inc - Submission_Utah Administration Rule R384-415
12/01/2020
Juul Labs Inc – Response to November 13, 2020 Letter From Subcommittee on Economic and Consumer Policy Chairman Raja Krishnamoorthi
11/17/2020
Juul Labs Inc - Comment_Request for Information on Vaping Products Associated with Lung Injuries; Dkt No FDA-2020-N-0567
06/19/2020
Juul Labs Inc - Comment_Proposed Data Collections Submitted for Public Comment and Recommendations_NYTS 2021-2023; Dkt No CDC-2019-0117
03/23/2020
Juul Labs Inc - Comment_Enforcement Priorities for ENDS and Other Deemed Products on the Market Without Premarket Authorization_Guidance for Industry; Dkt No FDA-2019-D-0661
01/31/2020
Juul Labs Inc - Comment_Premarket Tobacco Product Applications and Recordkeeping Requirements; Dkt No FDA-2019-N-2854
12/16/2019
Juul Labs Inc - Comment_Modifications to Compliance Policy for Certain Deemed Tobacco Products_Draft Guidance for Industry; Dkt No FDA-2019-D-0661
04/30/2019
Juul Labs Inc - Comment_Smoking Cessation and Related Indications_Developing Nicotine Replacement Therapy Drug Products_Draft Guidance for Industry; Dkt No FDA-2019-D-0297
04/23/2019
Juul Labs Inc - Comment_Use of Investigational Tobacco Products_Revised Draft Guidance for Industry and Investigators; Dkt No FDA-2014-D-1939
04/22/2019
Juul Labs Inc - Comment_Tobacco Product Application Review; Dkt No FDA-2018-N-3504
12/07/2018
Juul Labs Inc - Comment_Advance Notice of Proposed Rulemaking_Regulation of Flavors in Tobacco Products; Dkt No FDA-2017-N-6565
07/16/2018
Juul Labs Inc - Comment_Advance Notice of Proposed Rulemaking_Tobacco Product Standard for Nicotine Level of Combusted Cigarettes; Dkt No FDA-2017-N-6189
07/16/2018
See Other Pages
Harm Reduction
International Policies
Regulatory Filings
Disclosure and Transparency